- Singapore-based digital asset exchange Crypto.com continues its listing spree by adding yet another explosive altcoin to its platform.
According to a statement released on Thursday, the exchange is a protocol built on Ethereum (ETH) designed as a decentralized prediction market. Gnosis (GNO) listed its local presence.
Used to validate value transfer and transactions in the gnosis network. GNO tokenwas listed by one of the major cryptocurrency exchanges late last month. The crypto asset, which is traded at $182.84 at the time of writing and ranked 113th by market value, has increased by 1.5 percent compared to the last 24 hours and by more than 18 percent compared to last week. Compared to the last 30 days, GNO is trading with an increase of approximately 75 percent.
Enjoying impressive gains recently, Gnosis Chain is up for transactions on Thursday. Dai (DAI) It launched GnosisScan, a block explorer and analytics platform that uses its stablecoin.
The team of the altcoin project explained this project as follows:
“This tool will query/scan the blockchain for price information and transaction statistics with Etherscan’s familiar UX. The new Gnosis Chain explorer will support ERC20, ERC721 and ERC1155, allowing users to search for transaction details regarding configurations of other exchangeable, non-fungible token types.”
Coinbase, the largest US cryptocurrency exchange, also launched its trading services for GNO in July. Although the ERC-20 token has been performing well recently, it is still trading around 72 percent below its all-time high of $644.20 last November.
The well-known crypto trading platform Crypto.com now supports over 250 cryptocurrencies and stablecoins on its platform.
You can follow the current price action here.
Disclaimer: What is written here is not investment advice. Cryptocurrency investments are high-risk investments. Every investment decision is under the individual’s own responsibility. Finally, Koinfinans and the author of this content cannot be held responsible for personal investment decisions.